Life without COX 2 inhibitors.
作者信息
Shaughnessy Allen F, Gordon Andrea E
出版信息
BMJ. 2006 Jun 3;332(7553):1287-8. doi: 10.1136/bmj.332.7553.1287.
Abstract
摘要
相似文献
1
Life without COX 2 inhibitors.没有环氧化酶-2抑制剂的生活。
BMJ. 2006 Jun 3;332(7553):1287-8. doi: 10.1136/bmj.332.7553.1287.
2
Lumiracoxib (Prexige): a new selective COX-2 inhibitor.
Int J Clin Pract. 2004 Jun;58(6):606-11. doi: 10.1111/j.1368-5031.2004.00199.x.
3
NSAIDs: gastroprotection or selective COX-2 inhibitors?
Palliat Med. 2005 Mar;19(2):165; author reply 166-7. doi: 10.1191/0269216305pm991xx.
4
Efficacy of cyclooxygenase-2-specific inhibitors.环氧化酶-2特异性抑制剂的疗效。
Am J Med. 2001 Feb 19;110 Suppl 3A:6S-12S. doi: 10.1016/s0002-9343(00)00681-1.
5
COX-2-Selective NSAIDs: new and improved?COX-2 选择性非甾体抗炎药：新且有所改进？
JAMA. 2000 Sep 13;284(10):1297-9. doi: 10.1001/jama.284.10.1297.
6
New dogmas or old?新教条还是旧教条？
Gut. 2003 Sep;52(9):1379-81. doi: 10.1136/gut.52.9.1379.
7
Do COX-2 inhibitors give enough gastrointestinal protection?
Lancet. 2007 Feb 10;369(9560):439-40. doi: 10.1016/S0140-6736(07)60206-2.
8
NSAIDs: the emperor's new dogma?非甾体抗炎药：皇帝的新教条？
Gut. 2003 Sep;52(9):1376-8. doi: 10.1136/gut.52.9.1376.
9
Do cyclooxygenase-2 inhibitors provide benefits similar to those of traditional nonsteroidal anti-inflammatory drugs, with less gastrointestinal toxicity?环氧化酶-2抑制剂是否能提供与传统非甾体抗炎药类似的益处，同时胃肠道毒性更低？
Ann Intern Med. 2000 Jan 18;132(2):134-43. doi: 10.7326/0003-4819-132-2-200001180-00008.
10
Nonsteroidal anti-inflammatory analgesics and gastrointestinal protection in palliative care patients.
Palliat Med. 2004 Dec;18(8):739-40. doi: 10.1177/026921630401800813.
引用本文的文献
1
Population impact of regulatory activity restricting prescribing of COX-2 inhibitors: ecological study.限制环氧化酶-2 抑制剂处方的监管活动对人群的影响：生态研究。
Br J Clin Pharmacol. 2009 Nov;68(5):752-64. doi: 10.1111/j.1365-2125.2009.03500.x.
2
Short-term efficacy of physical interventions in osteoarthritic knee pain. A systematic review and meta-analysis of randomised placebo-controlled trials.物理干预对膝骨关节炎疼痛的短期疗效：随机安慰剂对照试验的系统评价和荟萃分析
BMC Musculoskelet Disord. 2007 Jun 22;8:51. doi: 10.1186/1471-2474-8-51.
3
Life without COX 2 inhibitors: opioids can be prescribed safely in osteoarthritis.没有环氧化酶-2抑制剂的生活：阿片类药物可安全用于骨关节炎的处方。
BMJ. 2006 Jun 17;332(7555):1452. doi: 10.1136/bmj.332.7555.1452.
本文引用的文献
1
Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials.选择性环氧化酶-2抑制剂和传统非甾体抗炎药会增加动脉粥样硬化血栓形成的风险吗？随机试验的荟萃分析。
BMJ. 2006 Jun 3;332(7553):1302-8. doi: 10.1136/bmj.332.7553.1302.
2
Glucosamine therapy for treating osteoarthritis.用于治疗骨关节炎的葡萄糖胺疗法。
Cochrane Database Syst Rev. 2005 Apr 18;2005(2):CD002946. doi: 10.1002/14651858.CD002946.pub2.
3
Exercise for osteoarthritis of the hip or knee.髋或膝骨关节炎的运动疗法
Cochrane Database Syst Rev. 2003(3):CD004286. doi: 10.1002/14651858.CD004286.
4
Right ballpark, wrong base: assessing safety of NSAIDs.
J Fam Pract. 2002 Jun;51(6):538.
5
Electromagnetic fields for the treatment of osteoarthritis.用于治疗骨关节炎的电磁场
Cochrane Database Syst Rev. 2002(1):CD003523. doi: 10.1002/14651858.CD003523.
6
Reporting of 6-month vs 12-month data in a clinical trial of celecoxib.在塞来昔布的一项临床试验中6个月与12个月数据的报告。
JAMA. 2001 Nov 21;286(19):2398; author reply 2399-400.
7
Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs.非甾体抗炎药的胃肠道毒性
N Engl J Med. 1999 Jun 17;340(24):1888-99. doi: 10.1056/NEJM199906173402407.
Zotero 插件